06/26/2025
Shola Fafunso is the U.S. country lead for the Skeletal Conditions business unit, responsible for driving the commercial efforts and aligning cross-functional teams to achieve business performance within this therapeutic area. But it's the patients who serve as his North Star.
In the latest installment of “The DNA of BioMarin,” we interviewed Shola, the vice president, U.S. skeletal conditions business unit, about his career journey that brought him into biotech, and more recently to BioMarin. For this series, we are drawing inspiration from the four bases that constitute DNA – A (adenine), T (thymine), C (cytosine) and G (guanine) – by asking employees to reflect on the role that Aspiration, Translation, Connection and Gratitude play in their everyday work.
Learn more about Shola and how the patients we serve motivate him and his team to build upon BioMarin's legacy in rare and genetically defined conditions: https://bit.ly/3IfTUKA